Global Information
회사소개 | 문의 | 비교리스트

세계의 스마트 필 시장

Smart Pills

리서치사 Global Industry Analysts, Inc.
발행일 2021년 04월 상품코드 958678
페이지 정보 영문 180 Pages 배송안내 1-2일 (영업일 기준)
가격
US $ 4,950 ₩ 6,436,000 PDF (Single User License)
US $ 14,850 ₩ 19,310,000 PDF (Global License to Company and its Fully-owned Subsidiaries)


세계의 스마트 필 시장 Smart Pills
발행일 : 2021년 04월 페이지 정보 : 영문 180 Pages

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계 스마트 필 시장 규모는 분석기간(2020년-2027년)에 11.4%의 연평균 복합 성장률(CAGR)로 성장할 전망이며, 2020년 3억 1,420만 달러에서 2027년에는 6억 6,820만 달러에 달할 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 식도는 분석기간 중 12%의 CAGR을 나타내고, 1억 5,250만 달러에 달할 전망입니다.

세계의 스마트 필(Smart Pills) 시장에 대해 조사했으며, 시장 점유율, 동향 및 전망, 성장요인, 지역별 시장 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

조사 대상 기업 사례

  • Capsovision, Inc.
  • Check-Cap Ltd.
  • Hq, Inc.
  • IntroMedic
  • Jinshan Science & Technology (Group) Co., Ltd.
  • Koninklijke Philips NV
  • Medtronic PLC
  • Olympus Corporation
  • Proteus Digital Health, Inc.
  • RF Co., Ltd.

목차

I. 서론, 조사 방법, 조사 범위

II. 주요 요약

  • 시장 개요
    • 경쟁사의 시장 점유율
    • 경쟁사의 시장 점유율 시나리오
    • Covid-19의 영향과 다가오는 세계의 경기후퇴
  • 주요 기업
  • 동향과 성장 촉진요인
  • 세계 시장 전망

III. 시장 분석

  • 지역별 시장 분석
  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

IV. 경쟁

  • 기업 개요 : 46개사
KSM 20.10.05

Abstract:

Global Smart Pills Market to Reach $668.2 Million by 2027

Amid the COVID-19 crisis, the global market for Smart Pills estimated at US$314.2 Million in the year 2020, is projected to reach a revised size of US$668.2 Million by 2027, growing at a CAGR of 11.4% over the analysis period 2020-2027. Esophagus, one of the segments analyzed in the report, is projected to record a 12% CAGR and reach US$152.5 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Small Intestine segment is readjusted to a revised 12.4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $92.7 Million, While China is Forecast to Grow at 10.9% CAGR

The Smart Pills market in the U.S. is estimated at US$92.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$116.9 Million by the year 2027 trailing a CAGR of 10.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.1% and 9.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.2% CAGR.

Large Intestine Segment to Record 9.4% CAGR

In the global Large Intestine segment, USA, Canada, Japan, China and Europe will drive the 9.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$49.6 Million in the year 2020 will reach a projected size of US$91.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$78.6 Million by the year 2027.

Select Competitors (Total 46 Featured) -

  • Capsovision, Inc.
  • Check-Cap Ltd.
  • Hq, Inc.
  • IntroMedic
  • Jinshan Science & Technology (Group) Co., Ltd.
  • Koninklijke Philips NV
  • Medtronic PLC
  • Olympus Corporation
  • Proteus Digital Health, Inc.
  • RF Co., Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Smart Pills by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 2: World 7-Year Perspective for Smart Pills by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
    • TABLE 3: World Current & Future Analysis for Esophagus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 4: World 7-Year Perspective for Esophagus by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 5: World Current & Future Analysis for Small Intestine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 6: World 7-Year Perspective for Small Intestine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Large Intestine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 8: World 7-Year Perspective for Large Intestine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 9: World Current & Future Analysis for Stomach by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 10: World 7-Year Perspective for Stomach by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 11: World Current & Future Analysis for Capsule Endoscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 12: World 7-Year Perspective for Capsule Endoscopy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 14: World 7-Year Perspective for Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 15: World Current & Future Analysis for Patient Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 16: World 7-Year Perspective for Patient Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 17: World Current & Future Analysis for Hospital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 18: World 7-Year Perspective for Hospital by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Diagnostic Center by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 20: World 7-Year Perspective for Diagnostic Center by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 21: World Current & Future Analysis for Research Institute by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 22: World 7-Year Perspective for Research Institute by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 23: USA Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 24: USA 7-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2020 & 2027
    • TABLE 25: USA Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 26: USA 7-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2020 & 2027
    • TABLE 27: USA Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 28: USA 7-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2020 & 2027
  • CANADA
    • TABLE 29: Canada Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 30: Canada 7-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2020 & 2027
    • TABLE 31: Canada Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 32: Canada 7-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2020 & 2027
    • TABLE 33: Canada Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 34: Canada 7-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2020 & 2027
  • JAPAN
    • TABLE 35: Japan Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 36: Japan 7-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2020 & 2027
    • TABLE 37: Japan Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 38: Japan 7-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2020 & 2027
    • TABLE 39: Japan Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 40: Japan 7-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2020 & 2027
  • CHINA
    • TABLE 41: China Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 42: China 7-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2020 & 2027
    • TABLE 43: China Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 44: China 7-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2020 & 2027
    • TABLE 45: China Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 46: China 7-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2020 & 2027
  • EUROPE
    • TABLE 47: Europe Current & Future Analysis for Smart Pills by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 48: Europe 7-Year Perspective for Smart Pills by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
    • TABLE 49: Europe Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 50: Europe 7-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2020 & 2027
    • TABLE 51: Europe Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 52: Europe 7-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2020 & 2027
    • TABLE 53: Europe Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 54: Europe 7-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2020 & 2027
  • FRANCE
    • TABLE 55: France Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 56: France 7-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2020 & 2027
    • TABLE 57: France Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 58: France 7-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2020 & 2027
    • TABLE 59: France Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 60: France 7-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2020 & 2027
  • GERMANY
    • TABLE 61: Germany Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 62: Germany 7-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2020 & 2027
    • TABLE 63: Germany Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 64: Germany 7-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2020 & 2027
    • TABLE 65: Germany Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 66: Germany 7-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2020 & 2027
  • ITALY
    • TABLE 67: Italy Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 68: Italy 7-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2020 & 2027
    • TABLE 69: Italy Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 70: Italy 7-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2020 & 2027
    • TABLE 71: Italy Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 72: Italy 7-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2020 & 2027
  • UNITED KINGDOM
    • TABLE 73: UK Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 74: UK 7-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2020 & 2027
    • TABLE 75: UK Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 76: UK 7-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2020 & 2027
    • TABLE 77: UK Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 78: UK 7-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2020 & 2027
  • REST OF EUROPE
    • TABLE 79: Rest of Europe Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 80: Rest of Europe 7-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2020 & 2027
    • TABLE 81: Rest of Europe Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 82: Rest of Europe 7-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2020 & 2027
    • TABLE 83: Rest of Europe Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 84: Rest of Europe 7-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 85: Asia-Pacific Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 86: Asia-Pacific 7-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2020 & 2027
    • TABLE 87: Asia-Pacific Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 88: Asia-Pacific 7-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2020 & 2027
    • TABLE 89: Asia-Pacific Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 90: Asia-Pacific 7-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2020 & 2027
  • REST OF WORLD
    • TABLE 91: Rest of World Current & Future Analysis for Smart Pills by Target Area - Esophagus, Small Intestine, Large Intestine and Stomach - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Rest of World 7-Year Perspective for Smart Pills by Target Area - Percentage Breakdown of Value Sales for Esophagus, Small Intestine, Large Intestine and Stomach for the Years 2020 & 2027
    • TABLE 93: Rest of World Current & Future Analysis for Smart Pills by Application - Capsule Endoscopy, Drug Delivery and Patient Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 94: Rest of World 7-Year Perspective for Smart Pills by Application - Percentage Breakdown of Value Sales for Capsule Endoscopy, Drug Delivery and Patient Monitoring for the Years 2020 & 2027
    • TABLE 95: Rest of World Current & Future Analysis for Smart Pills by End-Use - Hospital, Diagnostic Center and Research Institute - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 96: Rest of World 7-Year Perspective for Smart Pills by End-Use - Percentage Breakdown of Value Sales for Hospital, Diagnostic Center and Research Institute for the Years 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 46
Back to Top
전화 문의
F A Q